Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Safal Herbs Ltd (532034)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532034 NSE: Pharmaceuticals & Drugs | Small Cap | Safal Herbs Share Price
₹0.84 0.00 (0.00%)
As on 11-Mar'20 18:01
Safal Herbs Ltd (532034)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532034 NSE: Pharmaceuticals & Drugs | Small Cap | Safal Herbs Share Price
₹0.84 0.00 (0.00%)
As on 11-Mar'20 18:01
Key Metrics
Valuation Multiples
Market Cap
₹14 Cr.
Current Price
₹0.8
52-Week Low / High
₹1 / 1
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.3
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Steady versus 3-year growth rate
-100%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
9.62%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹10 Cr.
Face Value
₹1
All Time Low / High
₹0.00 / 72.85
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0.3% | 0.4% | 0.1% | 0% | 0.2% | 0.2% | 0.2% | -0.2% | -0.4% | 0% | - |
| Value Creation Index ⓘ | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0.6 | 0.6 | 1.5 | 1.3 | 1.4 | 1.4 | 1.8 | 0.3 | 0.1 | 0 | 0 |
| Sales YoY Gr. | - | 12.5% | 142.9% | -18.3% | 15.2% | -2.1% | 25.5% | -80.8% | -70.6% | -100% | - |
| Adj EPS ⓘ | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| YoY Gr. | - | NA | NA | NA | -40% | -100% | NA | NA | NA | NA | - |
| BVPS (₹) ⓘ | 0.9 | 0.9 | 0.9 | 8.8 | 8.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Adj Net Profit ⓘ | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Cash Flow from Ops. ⓘ | -0 | 0.2 | -0.3 | -0 | 4 | -0 | -4 | 0 | -0 | 0 | - |
| Debt/CF from Ops. ⓘ | 0 | 18 | -58 | -558.7 | 0 | 0 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -100% | -100% | -100% | -100% | ||||
| Adj EPS ⓘ | NA | -100% | NA | NA | ||||
| BVPSⓘ | -0.1% | -37% | -0.4% | 0% | ||||
| Share Price | -19.8% | -9.5% | -15.3% | -39.1% | ||||
Key Financial Parameters ⓘ
| Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0.2 | 0.3 | 0.2 | 0.5 | 0.3 | 0.4 | 0.1 | -0.2 | -0.4 | 0 | 0 |
| Op. Profit Mgn % ⓘ | 5 | 7.1 | 0.6 | 5.3 | 2.8 | 1.7 | -7.4 | -10 | -46.8 | 0 | 4.3 |
| Net Profit Mgn % ⓘ | 3.4 | 4.8 | 1 | 3.7 | 1.9 | 2.4 | 0.6 | -4.1 | -31.9 | 0 | 0 |
| Debt to Equity ⓘ | 0 | 0.4 | 1.8 | 1.8 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 5,911 | 6,253 | 4,478 | 7,375 | 4,317 | 2,313 | 1,842 | 9,568 | 32,317 | 0 | 626 |
| Cash Conv. Cycle ⓘ | 1,527 | 1,508 | 673 | 872 | 514 | 142 | -1 | 86 | 539 | 0 | 625 |
Valuation of Safal Herbs - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Safal Herbs Ltd FAQs
The current trading price of Safal Herbs on 11-Mar-2020 18:01 is ₹0.84.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Mar-2020 the market cap of Safal Herbs stood at ₹13.80 Cr
The latest P/E ratio of Safal Herbs as of 10-Mar-2020 is 0.00.
The latest P/B ratio of Safal Herbs as of 10-Mar-2020 is 1.54.
The 52-week high of Safal Herbs is ₹1.38 and the 52-week low is ₹0.84.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Safal Herbs is ₹0.34 ( Cr.) .
Data is not available for this company.
The key valuation ratios of Safal Herbs Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
No data found
About Safal Herbs Ltd
No data to display
You have 38 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
